Michael Bulman
Oxford Road
Manchester, ENG M139WL, United Kingdom
Manchester, ENG M139WL, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
Journal: Cancers
Published: December 04, 2022
Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer.
Journal: Journal of clinical pathology
Published: May 02, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Journal: British journal of cancer
Published: September 22, 2021
30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes.
Journal: European journal of human genetics : EJHG
Published: February 15, 2021
Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England.
Journal: European journal of human genetics : EJHG
Published: April 10, 2020
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.
Journal: Journal of medical genetics
Published: October 10, 2018
Sarcoma in neurofibromatosis 2: case report and review of the literature.
Journal: Familial cancer
Published: May 16, 2018
Non-invasive Intracranial Pressure Assessment in Brain Injured Patients Using Ultrasound-Based Methods.
Journal: Acta neurochirurgica. Supplement
Published: March 02, 2018
SMARCE1 mutation screening in classification of clear cell meningiomas.
Journal: Histopathology
Published: September 24, 2016
Last Updated: 09/26/2026